CD38 has emerged as a promising therapeutic target for cardio-protection as it has been implicated in the pathogenesis of several cardiovascular diseases including ischemia-reperfusion injury, atherosclerosis, cardiac arrhythmias, myocardial hypertrophy and pulmonary hypertension [53]. This evidence concerns the gene CD38 and chronic obstructive pulmonary disease.